Compare CMPS & KOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPS | KOP |
|---|---|---|
| Founded | 2020 | 1988 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Forest Products |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 662.5M | 536.4M |
| IPO Year | 2020 | 2006 |
| Metric | CMPS | KOP |
|---|---|---|
| Price | $6.60 | $30.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $16.86 | ★ $52.50 |
| AVG Volume (30 Days) | ★ 1.4M | 126.8K |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.08% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.78 |
| Revenue | N/A | ★ $1,923,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.94 |
| P/E Ratio | ★ N/A | $37.88 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.25 | $22.99 |
| 52 Week High | $8.20 | $35.61 |
| Indicator | CMPS | KOP |
|---|---|---|
| Relative Strength Index (RSI) | 44.99 | 63.40 |
| Support Level | $6.49 | $28.99 |
| Resistance Level | $7.45 | $30.22 |
| Average True Range (ATR) | 0.40 | 0.78 |
| MACD | -0.11 | 0.10 |
| Stochastic Oscillator | 15.02 | 78.42 |
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.